To meet the demands of the oral solid dosage (OSD) market, new techniques and technologies have emerged. While these have allowed developers to break new ground in harnessing innovative active pharmaceutical ingredients (APIs), the production of OSD therapeutics has become more and more complicated.

At Pfizer CentreOne, we help make the complex simple.

We leverage our state-of-the-art facilities and decades of experience to deliver
high-quality tablets, capsules and pellets — including highly potent, cytotoxic and low bioavailability drugs — to support even the most challenging tablets, capsules and pellets. This application note explores the OSD production and manufacturing methods we use to help achieve your goals.